Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.
Cesarini V, Martini M, Vitiani LR, Gravina GL, Di Agostino S, Graziani G, D'Alessandris QG, Pallini R, Larocca LM, Rossi P, Jannini EA, Dolci S.
Cesarini V, et al.
Oncotarget. 2017 Feb 21;8(8):13223-13239. doi: 10.18632/oncotarget.14656.
Oncotarget. 2017.
PMID: 28099939
Free PMC article.